Abilify and Mass - a phase IV clinical study of FDA data

Summary:

Mass is reported as a side effect among people who take Abilify (aripiprazole), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Vitamin D, and have Neuroendocrine tumor.

The phase IV clinical study analyzes which people have Mass when taking Abilify. It is created by eHealthMe based on reports of 97,308 people who have side effects when taking Abilify from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,443 Abilify users. Check the latest studies of Abilify.

What is Mass?

Mass is found to be associated with 2,258 drugs and 1,690 conditions by eHealthMe. Check the latest studies of Mass.

On Dec, 13, 2025

97,308 people reported to have side effects when taking Abilify.
Among them, 78 people (0.08%) have Mass.

Among these 78 people:

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and have Mass?

- Check whether Mass is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abilify:

Abilify (101,443 reports)

Mass treatments and more:

Mass (38,734 reports)

How severe was Mass and when was it recovered:

Mass in Abilify

Expand to all the drugs that have ingredients of aripiprazole:

Mass and drugs with ingredients of aripiprazole (94 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Common Abilify side effects:

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common drugs associated with Mass:

Browse all the drugs that are associated with Mass:

Mass (2,258 drugs)

Common conditions associated with Mass:

Rheumatoid arthritis: 3,141 reports
Blood pressure - high: 1,290 reports
Blood pressure increased: 1,289 reports
Osteoporosis: 1,145 reports
Ms: 1,104 reports
Ms hug: 1,102 reports
Pain: 1,018 reports
Alternative medicine - pain relief: 1,008 reports
Regional enteritis: 961 reports
Plasma cell myeloma: 960 reports

Browse all the conditions that are associated with Mass:

Mass (1,690 conditions)

Drugs similar to Abilify and Mass :

Related publications that referenced our studies

Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.